DESTINATION: TEZEPELUMAB LONG-TERM SAFETY AND EFFICACY VERSUS PLACEBO IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA

被引：1
|
作者：
Menzies-Gow, A. [1 ]
Wechsler, M. E. [2 ]
Brightling, C. E. [3 ]
Korn, S. [4 ,5 ]
Bednarczyk, A. [6 ]
Ponnarambil, S. [7 ]
Almqvist, G. [8 ]
Lawson, K. [9 ,10 ]
Caveney, S. [11 ]
Bowen, K. [12 ]
Colice, G. [9 ]
机构：
[1] Royal Brompton & Harefield Hosp, London, England
[2] Natl Jewish Hlth, Denver, CO USA
[3] Univ Leicester, Inst Lung Hlth, NIHR Leicester Biomed Res Ctr, Leicester, Leics, England
[4] IKF Pneumol Mainz, Mainz, Germany
[5] Thoraxklin Heidelberg, Heidelberg, Germany
[6] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Warsaw, Poland
[7] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Cambridge, England
[8] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Gothenburg, Sweden
[9] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Gaithersburg, MD USA
[10] Cytel Inc, Cambridge, MA USA
[11] Amgen Inc, Global Dev, R&D, Thousand Oaks, CA USA
[12] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Biometr, Gaithersburg, MD USA
来源：
THORAX | 2022年 / 77卷
关键词：
D O I：
10.1136/thorax-2022-BTSabstracts.53
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S47
引用
收藏
页码：A32 / A32
页数：1
相关论文
共 50 条
  • [31] EFFICACY OF DUPILUMAB VERSUS TEZEPELUMAB IN ASTHMA PATIENTS: MATCHING-ADJUSTED INDIRECT COMPARISON OF LONG-TERM EXTENSION TRIALS
    Chapman, K.
    Guyot, P.
    Ledanois, O.
    Soliman, M.
    Wang, Z.
    Xu, Y.
    Nangia, A.
    Cheng, W.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S51 - S51
  • [32] Efficacy Of Tezepelumab In Patients With Severe, Uncontrolled Asthma By Specific Perennial Allergen Immunoglobulin E Thresholds
    Lindsley, Andrew
    Colice, Gene
    Martin, Neil
    Spahn, Joseph
    Martin, Nicole
    Ambrose, Chris
    Hoyte, Flavia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB18 - AB18
  • [33] Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma
    Murphy, Kevin
    Jacobs, Joshua
    Bjermer, Leif
    Fahrenholz, John M.
    Shalit, Yael
    Garin, Margaret
    Zangrilli, James
    Castro, Mario
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (06): : 1572 - +
  • [34] Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
    Menzies-Gow, Andrew
    Corren, Jonathan
    Bourdin, Arnaud
    Chupp, Geoffrey
    Israel, Elliot
    Griffiths, Janet
    Hellqvist, Asa
    Bowen, Karin
    Kaur, Primal
    Almqvist, Gun
    Ponnarambil, Sandhia
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB249 - AB249
  • [35] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Sex: Results From the Phase 3 Navigator Study
    Kraft, M.
    Chupp, G. L.
    Reeh, K.
    Lindsley, A. W.
    Cook, B.
    Hunter, G.
    Ambrose, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [36] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study
    Carr, Tara F.
    Moore, Wendy C.
    Kraft, Monica
    Brusselle, Guy
    Castro, Mario
    Chupp, Geoffrey L.
    Wechsler, Michael E.
    Hunter, Gillian
    Lindsley, Andrew W.
    Llanos, Jean-Pierre
    Burke, Luke K.
    Chandarana, Shradha
    Ambrose, Christopher S.
    ADVANCES IN THERAPY, 2024, 41 (07) : 2978 - 2990
  • [37] Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma
    Park, Hae-Sim
    Lee, Sang Haak
    Lee, Sook Young
    Kim, Mi-Kyeong
    Lee, Byung Jae
    Werkstrom, Viktoria
    Barker, Peter
    Zangrilli, James G.
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2019, 11 (04) : 508 - 518
  • [38] Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma
    Ohta, Ken
    Adachi, Mitsuru
    Tohda, Yuji
    Kamei, Tadashi
    Kato, Motokazu
    Fitzgerald, J. Mark
    Takanuma, Masayuki
    Kakuno, Tadahiro
    Imai, Nobuyuki
    Wu, Yanping
    Aurivillius, Magnus
    Goldman, Mitchell
    ALLERGOLOGY INTERNATIONAL, 2018, 67 (02) : 266 - 272
  • [39] Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study
    Di Bona, Danilo
    Fiorino, Irene
    Taurino, Marialuisa
    Frisenda, Flavia
    Minenna, Elena
    Pasculli, Carlo
    Kourtis, Georgios
    Rucco, Anna Simona
    Nico, Andrea
    Albanesi, Marcello
    Giliberti, Lucia
    D'Elia, Luciana
    Caiaffa, Maria Filomena
    Macchia, Luigi
    RESPIRATORY MEDICINE, 2017, 130 : 55 - 60
  • [40] Tezepelumab can restore normal lung function in patients with severe, uncontrolled asthma
    Pavord, Ian Douglas
    Brightling, Christopher E.
    Korn, Stephanie
    Martin, Nicole
    Ponnarambil, Sandhia
    Molfino, Nestor A.
    Parnes, Jane R.
    Cook, Bill
    Ambrose, Christopher S.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
12345